Arcus Biosciences (RCUS) Technical (Analysis) Reports Arcus Biosciences ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Arcus Biosciences (RCUS)
Technical Analysis Report for NYSE stock RCUS Arcus Biosciences. Dated: 25 Sep 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange
If you are looking for Tomorrow's Movement Predictions for NYSE stock RCUS Arcus Biosciences then click here. or read Experts views on Arcus Biosciences or Forecast & share price targets of Arcus Biosciences
Arcus Biosciences Opened at 25.60 and Closed at: 24.98, which is -0.32% of previous session's close. It moved within a range of 24.34 and 25.60
The session was a Bearish session with an average volume of 1140260, which is -78.77% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
Support for tomorrow is 24.03 and resistance for tomorrow is 25.29
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 24.35, 23.71 resistance for tomorrow's hourly charts is 25.61, 26.23
10 Day SMA for Arcus Biosciences (RCUS) is 25.31 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Arcus Biosciences (RCUS) is 26.96 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Arcus Biosciences (RCUS) is 28.19 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 27.13 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Arcus Biosciences is 24.74 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Arcus Biosciences is at 26.96 and 200 DMA is at 24.74, while 50 DMA and 100 DMA are at 28.19 and 27.13 respectively
Arcus Biosciences (RCUS) moving average of 20 SMA is at 26.96 and 20 EMA is at 26.64
| Date | Closing Price | 20 SMA | 20 EMA |
| 25 Fri Sep | 24.98 | 26.96 | 26.64 |
| 24 Thu Sep | 25.06 | 27.24 | 26.81 |
| 23 Wed Sep | 26.39 | 27.53 | 26.99 |
| 22 Tue Sep | 26.87 | 27.78 | 27.05 |
| 21 Mon Sep | 25.95 | 27.95 | 27.07 |
| 18 Fri Sep | 25.24 | 28.17 | 27.19 |
Arcus Biosciences (RCUS) moving average of 50 SMA is at 28.19 and 50 EMA is at 27.44
| Date | Closing Price | 50 SMA | 50 EMA |
| 25 Fri Sep | 24.98 | 28.19 | 27.44 |
| 24 Thu Sep | 25.06 | 28.23 | 27.54 |
| 23 Wed Sep | 26.39 | 28.27 | 27.64 |
| 22 Tue Sep | 26.87 | 28.3 | 27.69 |
| 21 Mon Sep | 25.95 | 28.33 | 27.72 |
| 18 Fri Sep | 25.24 | 28.37 | 27.79 |
Arcus Biosciences (RCUS) moving average of 100 SMA is at 27.13 and 100 EMA is at 26.82
| Date | Closing Price | 100 SMA | 100 EMA |
| 25 Fri Sep | 24.98 | 27.13 | 26.82 |
| 24 Thu Sep | 25.06 | 27.14 | 26.86 |
| 23 Wed Sep | 26.39 | 27.15 | 26.9 |
| 22 Tue Sep | 26.87 | 27.14 | 26.91 |
| 21 Mon Sep | 25.95 | 27.13 | 26.91 |
| 18 Fri Sep | 25.24 | 27.13 | 26.93 |
Arcus Biosciences (RCUS) moving average of 200 SMA is at 24.74 and 200 EMA is at 24.22
| Date | Closing Price | 200 SMA | 200 EMA |
| 25 Fri Sep | 24.98 | 24.74 | 24.22 |
| 24 Thu Sep | 25.06 | 24.74 | 24.21 |
| 23 Wed Sep | 26.39 | 24.75 | 24.2 |
| 22 Tue Sep | 26.87 | 24.74 | 24.18 |
| 21 Mon Sep | 25.95 | 24.73 | 24.15 |
| 18 Fri Sep | 25.24 | 24.73 | 24.13 |
Abbvie Inc has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Abbvie Inc, about 17.95% more returns!
Astrazeneca Plc has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Astrazeneca Plc, about 16.86% more returns!
Brookdale Senior has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Brookdale Senior, about 9.28% more returns!
Chemed Corp has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Chemed Corp, about 12.34% more returns!
Charles River has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Charles River, about 14.94% more returns!
Davita Inc has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Davita Inc, about 13.26% more returns!
Emergent Biosolutions has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Emergent Biosolutions, about 29.37% more returns!
Fresenius Medical has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Fresenius Medical, about 12.71% more returns!
Globus Medical has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Globus Medical, about 4.3% more returns!
Humana Inc has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Humana Inc, about 17.69% more returns!
Iqvia Holdings has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Iqvia Holdings, about 17.77% more returns!
Johnson Johnson has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Johnson Johnson, about 15.67% more returns!
Eli Lilly has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Eli Lilly, about 15.31% more returns!
Mckesson Corporation has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Mckesson Corporation, about 11.49% more returns!
Arcus Biosciences has performed better than Novo Nordisk in short term. Holding Arcus Biosciences could be a better choice for now!
Perrigo Company has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Perrigo Company, about 21.04% more returns!
Universal Health has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Universal Health, about 18.67% more returns!
Unitedhealth Group has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Unitedhealth Group, about 10.35% more returns!
Zimmer Biomet has performed better than Arcus Biosciences in short term. You could have earned much better returns by investing in Zimmer Biomet, about 4.7% more returns!
Arcus Biosciences Technical analysis of indicators
Price action analysis of Arcus Biosciences (RCUS) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arcus Biosciences stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Arcus Biosciences in short term and the sell signal is strong.
Arcus Biosciences Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arcus Biosciences in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Arcus Biosciences is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 25.22 and Arcus Biosciences RCUS stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Arcus Biosciences RCUS stock. Volume based technical analysis of Arcus Biosciences RCUS stock is negative.
Arcus Biosciences Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NYSE stock RCUS Arcus Biosciences These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And RCUS Experts View which covers a lot of information including buying and selling signals
RCUS future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Arcus Biosciences or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Arcus Biosciences (RCUS) Technical (Analysis) Reports Arcus Biosciences ["Technical Analysis"] Reports -NYSE Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance


